Elicio Therapeutics ELTX
NASDAQ ELTX
$1.63 +0.02 (+1.24%)
At close: Nov 11, 2026 · 4:00 PM EST

Elicio Therapeutics (ELTX) Net Margin (2020 - 2024)

Updated

Elicio Therapeutics' Net Margin was -1225.90% in FY2022, down 1033.15 percentage points from -192.76% in FY2021.

Analysis

Elicio Therapeutics (ELTX) Net Margin (2020 - 2024) Analysis & Trends

  • Per Business Quant data, Net Margin in earlier years was -192.76% in FY2021 (+2588.74 pp) and -2781.49% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.83%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.24%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 28.01%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 20.69%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 37.28%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 29.27%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 19.55%
10 Elicio Therapeutics 45.57 Mn -42.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -7,884.67%
Dec 31, 2023 -11,932.00%
Sep 30, 2023 -4,332.52%
Jun 30, 2023 -19,382.05%
Jun 30, 2022 -1,117.76%
Mar 31, 2022 -428.40%
Dec 31, 2021 57.40%
Sep 30, 2021 -1,075.62%
Jun 30, 2021 -3,161.48%
Mar 31, 2021 -9,888.68%
Dec 31, 2020 -6,290.85%
Sep 30, 2020 -2,136.52%
Jun 30, 2020 -2,790.26%
Mar 31, 2020 -1,528.55%
API Access

Elicio Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=ELTX&period=max&api_key=YOUR_API_KEY